Acyclovir
ACYCLOVIR ORAL SUSPENSION, USP
Approved
Approval ID
47a4af6e-1111-458b-9a79-2199b78d8a80
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 11, 2022
Manufacturers
FDA
VistaPharm, Inc.
DUNS: 116743084
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Acyclovir
PRODUCT DETAILS
NDC Product Code66689-342
Application NumberANDA213951
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 11, 2022
Generic NameAcyclovir
INGREDIENTS (8)
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ACYCLOVIRActive
Quantity: 200 mg in 5 mL
Code: X4HES1O11F
Classification: ACTIB